NCT06565364View on ClinicalTrials.gov

Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients

CompletedOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions

ThrombocytopeniaAntibodies Drug Specific

Interventions

DIAGNOSTIC_TEST

"ZYMUTEST™ HIA immunoglobulin g ELISA (enzyme-linked immunosorbent assay )"

The enzyme-linked immunosorbent assay is an in vitro test done in the laboratory to detect specific antibodies against heparin/platelet factor-4 and protamine/heparin complexes.

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT06565364 - Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter